Condition: Neuropathic Pain

Neuropathic Pain

CINP: 1 study 

WEX TTX-CINP-202 - This is a randomized, double-blind, placebo-controlled, multicenter trial of the efficacy and safety of TTX in subjects with established CINP.  

Who’s Eligible/Study Details: 

  • Adults 21+ 
  • must have ongoing moderate to severe neuropathic pain related to a prior course of platinum and/or taxane chemotherapy and have no clinical evidence of actively progressive disease 
  • Hormone therapy is allowed, opioid and cytotoxic therapy is not 
  • 13 Week duration total 
  • 4-day BID injection 
  • 90-day washout period for chemotherapy 


If you would like more information please contact clinical trials research coordinator at DJL Research in Charlotte 704-247-9179, x-207